Last C$2.31 CAD
Change Today -0.07 / -2.94%
Volume 84.7K
TMD On Other Exchanges
As of 3:58 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

titan medical inc (TMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/7/14 - C$2.76
52 Week Low
09/24/13 - C$0.38
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TITAN MEDICAL INC (TMD)

Related News

No related news articles were found.

titan medical inc (TMD) Related Businessweek News

No Related Businessweek News Found

titan medical inc (TMD) Details

Titan Medical Inc., a development stage company, is engaged in the design and development of robotic surgical system for application in minimally invasive surgery (MIS). It is developing Single Port Orifice Robotic Technology (SPORT) Surgical System, a single-incision robotic surgical system that comprises a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures. The SPORT Surgical System is being designed to expand robotic surgery into areas of surgical specialties and simple and complex procedures that are under-serviced, and to allow surgeons to perform procedures within small to medium size surgical spaces, such as general surgery and cholecystectomy. Titan Medical Inc. has strategic development relationship with Ximedica LLC in connection with the development of the SPORT Surgical System. The company is headquartered in Toronto, Canada.

titan medical inc (TMD) Top Compensated Officers

Chairman, Chief Executive Officer and Member ...
Total Annual Compensation: C$167.0K
President, Director and Member of Audit Commi...
Total Annual Compensation: C$236.9K
Chief Financial Officer and Secretary
Total Annual Compensation: C$156.8K
Compensation as of Fiscal Year 2013.

titan medical inc (TMD) Key Developments

Titan Medical Inc. Appoints Dennis Fowler as Executive Vice President, Clinical and Regulatory Affairs

Titan Medical Inc. announced that Dr. Dennis Fowler, who currently serves as the company's Director of Clinical Affairs, has been appointed to the newly-created position of Executive Vice President, Clinical and Regulatory Affairs. In his new role, Dr. Fowler will be responsible for all of Titan's clinical and regulatory affairs, including pre-clinical testing and clinical development. He will also oversee Titan's U.S. and international regulatory pathways for the Company's Single Port Orifice Robotic Technology (SPORT(TM)) Surgical System. He will work closely with the clinical and regulatory departments of Ximedica, a premier product development firm for the medical industry partnered with Titan. Dr. Fowler has been Director of Clinical Affairs at Titan since September 2013. Prior to that, he was a consultant to the company. He is a co-inventor of the single-incision Insertable Robotic Effector Platform (IREP) technology, which was licensed from Columbia University for use in Titan's SPORT(TM) Surgical System.

Titan Medical Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Titan Medical Inc. reported unaudited earnings results for the six months ended June 30, 2014. For the period, the company reported net and comprehensive loss of $6,781,692 which included a loss on change in fair market value of warrants of $4,237,546 compared to a net and comprehensive loss of $2,195,271 for the three ended June 30, 2013. For the six months, the company reported net and comprehensive loss of $10,392,634, which included a loss on change in fair market value of warrants of $4,237,546 and $5,697,868, compared to a net and comprehensive loss of $4,510,727, for the six months ended June 30, 2013.

Titan Medical Inc. Announces Executive Changes

Titan Medical Inc. announced that Mr. Joe Talarico, Senior Vice President Business Development has resigned his position with the company. In the interim John Hargrove, Chairman and CEO will assume the responsibilities for Business Development.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMD:CN C$2.31 CAD -0.07

TMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Federal-Mogul Holdings Corp $16.10 USD -0.15
View Industry Companies

Industry Analysis


Industry Average

Valuation TMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 8.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TITAN MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at